Prazpronto 40 mg Spot-on solution for medium cats

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

Praziquantel

Available from:

Chanelle Pharmaceuticals Manufacturing Limited

ATC code:

QP52AA01

INN (International Name):

Praziquantel

Dosage:

40 milligram(s)

Pharmaceutical form:

Spot-on solution

Prescription type:

CAM: Companion Animal Medicine as defined in relevant national legislation

Therapeutic area:

praziquantel

Authorization status:

Authorised

Authorization date:

2020-09-25

Summary of Product characteristics

                                Health Products Regulatory Authority
29 September 2020
CRN0099Z3
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Prazpronto 40 mg Spot-on solution for medium cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 1.0 ml pipette contains:
ACTIVE SUBSTANCE:
Praziquantel 40 mg
EXCIPIENT(S):
Butylhydroxytoluene (E321) 1.0 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Spot-on solution.
Clear colourless to pale amber solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of tapeworm infections in cats weighing from 2.5 to
5 kg: _Dipylidium caninum_ (immature and adult), _Taenia_
spp (immature and adult) and _Echinococcus multilocularis_
4.3 CONTRAINDICATIONS
Do not use on cats weighing less than 2.5 kg bodyweight.
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Do not allow recently treated animals to groom each other.
When applying the veterinary medicinal product, special attention
should be paid in long hair breeds in order to ensure that it
is applied directly to the skin and not on the hair, as this could
lead to a lower bioavailability of the active substance and thus,
to a reduced activity.
Shampooing and immersion of the animals in water directly after
treatment may reduce the efficacy of the product. Treated
animals therefore should not be bathed until the solution has dried.
It is recommended to treat all the animals living in the same
household concomitantly.
When infection with the cestode _Dipylidium caninum_ has been
confirmed, concomitant treatment against intermediate hosts,
such as fleas and lice, should be discussed with a veterinarian to
prevent re-infection.
Health Products Regulatory Authority
29 September 2020
CRN0099Z3
Page 2 of 5
Parasite resistance to any particular class of anthelmintic may
develop following frequent, repeated use of an anthelmintic of
that class
                                
                                Read the complete document
                                
                            

Search alerts related to this product